基于树突细胞的细胞技术的开发,用于瘤疾病的免疫治疗
Vasily Kurilin1, Alina Alshevskaya2, Sergey Sennikov1,2
1Laboratory of Molecular Immunology, Federal State Budgetary Scientific Institution "Research Institute of Fundamental and Clinical Immunology" (RIFCI), 630099 Novosibirsk, Russia.
Biomedicines
|March 28, 2024
概括
基于树突细胞的免疫疗法可以增强免疫系统对抗癌症. DNA和RNA结构有效地将瘤抗原传递给树突细胞,改善癌症治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 基于树突细胞 (DC) 的疫苗接种利用患者的免疫系统消除瘤细胞.
- 了解癌症中的DC分化和功能是开发有效免疫疗法的关键.
- 基本的DC功能包括抗原呈现,T-淋巴细胞启动和诱导抗原特异性免疫反应.
研究的目的:
- 开发用于癌症免疫治疗的成熟树突细胞体外生成的协议.
- 优化瘤抗原传递系统,以增强树突细胞疫苗接种.
- 为了改善抗原特异性细胞毒性T淋巴细胞对抗癌症的诱导.
主要方法:
- 对树突细胞的各种瘤相关抗原递送系统进行了研究.
- 溶解物,蛋白质 () 和DNA/RNA结构的抗原传递效率的比较.
- 专注于产生功能成熟的树突细胞,能够捕获,处理和呈现抗原.
主要成果:
- DNA和RNA结构被证明是最有效的,用于向树突细胞传递免疫性瘤抗原表位.
- 这些结构增强了树突细胞诱导抗原特异性细胞毒性T淋巴细胞的能力.
- 建立了用于免疫治疗的强大树突细胞体外生成的协议.
结论:
- 基于树突细胞的疗法是抗原特异性癌症免疫疗法的现代方法.
- DNA/RNA结构简化了编码瘤抗原和调节分子的治疗剂的创建.
- 未来的研究重点是优化DC诱导的细胞毒性T淋巴细胞活性和基于细胞的治疗开发.
相关概念视频
Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
Cancer Vaccines
363
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
363
Cytotoxic T Cells-mediated Immune Response
907
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
907


